RecruitingNot ApplicableNCT07063537

Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma

Evaluation of the Accuracy and Reproducibility of Visual Field Testing Using a Virtual Reality Head-Mounted Device for Patients With Early, Moderate, and Advanced Glaucoma


Sponsor

Nova Scotia Health Authority

Enrollment

60 participants

Start Date

Dec 14, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to evaluate the feasibility of using virtual reality based visual field testing to monitor glaucoma in a clinical setting. This will be done through comparison of a virtual reality (VR) based device to the current gold standard Ziess Humphrey Field Analyzer (HFA). The main questions the study aims to answer are: * Can both devices produce similar results in terms of detecting visual field defects and progression? * Does the stage (early, moderate, advanced) of glaucoma impact results between the two devices? Participants will perform both a standard and a VR based visual field test at each visit, for a total of 5 visits.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a virtual reality (VR) headset can accurately and reliably measure visual field defects in people with glaucoma — a condition that damages the nerve connecting the eye to the brain — potentially offering a more accessible alternative to traditional clinic-based vision field testing. **You may be eligible if...** - You are over 18 years old - You have been diagnosed with primary open-angle glaucoma - You are able to perform visual field testing - You are able to consent to participate in research **You may NOT be eligible if...** - You have secondary glaucoma or a different type of optic nerve disease - You have had previous eye surgery (other than cataract surgery or minimally invasive glaucoma procedures) - You have significant lens clouding that could affect test results - You are pregnant, have a seizure disorder, have a cardiac pacemaker or implantable device, or have severe dizziness or balance problems Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEVirtual Reality Visual Field (VR-VF)

Both devices administer a standard visual field test. The Humphrey is the gold standard desk top model and the VR-VF is a virtual reality headset designed to deliver visual field testing


Locations(1)

Eadie Technologies Inc

Halifax, Nova Scotia, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07063537


Related Trials